(225 ILCS 85/19.1)
(Section scheduled to be repealed on January 1, 2023)
Dispensing opioid antagonists.
(a) Due to the recent rise in opioid-related deaths in
Illinois and the existence of an opioid antagonist that can
reverse the deadly effects of overdose, the General Assembly
finds that in order to avoid further loss where possible, it is
responsible to allow greater access of such an antagonist to
those populations at risk of overdose.
(b) Notwithstanding any general or special law to the
contrary, a licensed pharmacist may dispense an opioid antagonist
in accordance with written, standardized procedures or
protocols developed by the Department with the Department of
Public Health and the Department of Human Services if the
procedures or protocols are filed at the pharmacy before
implementation and are available to the Department upon
(c) Before dispensing an opioid antagonist pursuant to this
Section, a pharmacist shall complete a training program
approved by the Department of Human Services pursuant to
Section 5-23 of the Substance Use Disorder Act. The training program shall include, but not be
limited to, proper documentation and quality assurance.
(d) For the purpose of this Section, "opioid antagonist" means a drug that binds to opioid receptors and blocks or inhibits the effect of opioids acting on those receptors, including, but not limited to, naloxone hydrochloride or any other similarly acting and equally safe drug approved by the U.S. Food and Drug Administration for the treatment of drug overdose.
(Source: P.A. 99-480, eff. 9-9-15; 99-642, eff. 7-28-16; 100-759, eff. 1-1-193